Regulation and Function of hTERT in Human Cells

hTERT 在人类细胞中的调控和功能

基本信息

  • 批准号:
    8239518
  • 负责人:
  • 金额:
    $ 34.48万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-08-15 至 2015-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Telomere homeostasis regulates both chromosomal stability and cell replicative lifespan in mammalian cells. As a consequence, alterations in telomere biology play critical roles in the pathogenesis of human cancer and may contribute to aging. Indeed, studies in both human and animal models indicate that telomeres and telomerase, the reverse transcriptase that maintains telomere structure, serve dual roles in oncogenesis, acting both to suppress and facilitate neoplastic transformation. Moreover, mutations of telomerase components required for catalytic activity, TERT and TERC, are found in diseases characterized by stem cell failure including dyskeratosis congenita, subsets of aplastic anemia and idiopathic pulmonary fibrosis. Taken together, these telomerase plays a key role in maintaining telomeres, accumulating evidence suggests that the catalytic observations implicate telomerase as a critical link between cancer and aging. Although it is clear that subunit of TERT contributes to both normal and malignant cell physiology beyond its role in telomere maintenance. Specifically, expression of TERT drives tumor formation under situations when telomere length is not limiting and alters stem cell function in a manner that is independent of the expression of TERC. In prior work, we found that TERT is expressed in cycling primary pre-senescent human fibroblasts and that this low-level expression of telomerase controls proliferative lifespan. During the past funding period, we have investigated the role of TERT in both normal and malignant mammalian cells and found that in addition to its role in telomere maintenance, TERT regulates overall chromatin structure. Moreover, we and others have identified several novel protein complexes that associate with TERT. In recent work, we have found that TERT interacts with the RNA component of mitochondrial RNA processing endoribonuclease (RMRP), a gene that is mutated in the inherited pleiotropic syndrome Cartilage-Hair Hypoplasia. TERT and RMRP form an RNA dependent RNA polymerase (RdRP). These new observations suggest that TERT forms several distinct enzymatic complexes and provide a foundation to understand extra-telomeric functions of TERT. This proposal focuses on investigating the role of these newly identified TERT complexes in senescence and cancer. Specifically, biochemical, genetic and molecular biological approaches will be applied to investigate the role of the TERT-RMRP RdRP in chromatin homeostasis, senescence and transformation, to understand the roles of TERT-RMRP complexes in normal cells and tissues and to elucidate the function of TERT protein complexes in the regulation of senescence. These studies will not only provide new insights into the roles of various TERT complexes in aging and cancer but will also enhance our understanding of heterochromatin regulation. In addition, these studies will provide a foundation for strategies to manipulate these complexes therapeutically. PUBLIC HEALTH RELEVANCE: Although it is clear that telomeres and telomerase play important roles in aging and cancer, we lack a complete understanding of the roles of telomerase components in senescence and transformation. This proposal focuses on deciphering the role of newly identified TERT complexes in both normal and malignant cells and tissues. These biochemical, cell and animal- based studies will not only provide insight into the biology of TERT complexes but will serve as a foundation for translational studies for the development of novel therapeutic agents.
描述(由申请人提供):端粒稳态调节哺乳动物细胞的染色体稳定性和细胞复制寿命。因此,端粒生物学的改变在人类癌症的发病机制中起着关键作用,并可能导致衰老。事实上,人类和动物模型的研究表明,端粒和端粒酶(维持端粒结构的逆转录酶)在肿瘤发生中起双重作用,既抑制又促进肿瘤转化。此外,在以干细胞衰竭为特征的疾病中,包括先天性角化不良、再生障碍性贫血亚群和特发性肺纤维化,发现了催化活性所需的端粒酶组分TERT和TERC的突变。综上所述,这些端粒酶在维持端粒中起着关键作用,越来越多的证据表明,催化观察表明端粒酶是癌症和衰老之间的关键联系。虽然很明显,TERT亚基在正常和恶性细胞生理上的贡献超出了它在端粒维持中的作用。具体来说,TERT的表达在端粒长度不受限制的情况下驱动肿瘤形成,并以独立于TERC表达的方式改变干细胞功能。在之前的工作中,我们发现TERT在循环原发性衰老前人类成纤维细胞中表达,并且端粒酶的低水平表达控制增殖寿命。在过去的资助期内,我们研究了TERT在正常和恶性哺乳动物细胞中的作用,发现除了在端粒维持中起作用外,TERT还调节整体染色质结构。此外,我们和其他人已经确定了几种与TERT相关的新型蛋白质复合物。在最近的研究中,我们发现TERT与线粒体RNA加工核糖核酸内切酶(RMRP)的RNA组分相互作用,RMRP是遗传性多效性综合征软骨毛发发育不全中发生突变的基因。TERT和RMRP形成RNA依赖性RNA聚合酶(RdRP)。这些新的观察结果表明,TERT形成了几种不同的酶复合物,并为了解TERT的端粒外功能提供了基础。本研究的重点是研究这些新发现的TERT复合物在衰老和癌症中的作用。具体而言,将应用生化、遗传和分子生物学等方法研究TERT- rmrp RdRP在染色质稳态、衰老和转化中的作用,了解TERT- rmrp复合物在正常细胞和组织中的作用,阐明TERT蛋白复合物在衰老调控中的功能。这些研究不仅将为各种TERT复合物在衰老和癌症中的作用提供新的见解,而且将增强我们对异染色质调控的理解。此外,这些研究将为治疗性地操纵这些复合物的策略提供基础。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

William C. Hahn其他文献

SV40 small T antigen and PP2A phosphatase in cell transformation
  • DOI:
    10.1007/s10555-008-9116-0
  • 发表时间:
    2008-01-23
  • 期刊:
  • 影响因子:
    8.700
  • 作者:
    Anna A. Sablina;William C. Hahn
  • 通讯作者:
    William C. Hahn
A compendium of Amplification-Related Gain Of Sensitivity genes in human cancer
人类癌症中与扩增相关的敏感性增益基因纲要
  • DOI:
    10.1038/s41467-025-56301-2
  • 发表时间:
    2025-01-27
  • 期刊:
  • 影响因子:
    15.700
  • 作者:
    Veronica Rendo;Michael Schubert;Nicholas Khuu;Maria F. Suarez Peredo Rodriguez;Declan Whyte;Xiao Ling;Anouk van den Brink;Kaimeng Huang;Michelle Swift;Yizhou He;Johanna Zerbib;Ross Smith;Jonne Raaijmakers;Pratiti Bandopadhayay;Lillian M. Guenther;Justin H. Hwang;Amanda Iniguez;Susan Moody;Ji-Heui Seo;Elizabeth H. Stover;Levi Garraway;William C. Hahn;Kimberly Stegmaier;René H. Medema;Dipanjan Chowdhury;Maria Colomé-Tatché;Uri Ben-David;Rameen Beroukhim;Floris Foijer
  • 通讯作者:
    Floris Foijer
The present and future of the Cancer Dependency Map
癌症依赖图谱的现在与未来
  • DOI:
    10.1038/s41568-024-00763-x
  • 发表时间:
    2024-10-28
  • 期刊:
  • 影响因子:
    66.800
  • 作者:
    Rand Arafeh;Tsukasa Shibue;Joshua M. Dempster;William C. Hahn;Francisca Vazquez
  • 通讯作者:
    Francisca Vazquez
Developing a library of authenticated Traditional Chinese Medicinal (TCM) plants for systematic biol
开发经过认证的中药 (TCM) 植物库,用于系统生物分析
  • DOI:
  • 发表时间:
    2011
  • 期刊:
  • 影响因子:
    0
  • 作者:
    David Eisenberg;Eric S. J. Harris;Bruce A. Littlefield;Shugeng Cao;Jane A. Craycroft;Robert Scholten;Peter E. Bayliss;Yanling Fu;Wenquan Wang;Yan;Zhongzhen Zhao;Hubiao Chen;Yong Liu;Ted J. Kaptchuk;William C. Hahn;Xiaoxin Wang;Thomas M. Roberts;C. Shamu;Jon Clardy
  • 通讯作者:
    Jon Clardy
CDK8 is a colorectal cancer oncogene that regulates β-catenin activity
CDK8 是一种调节β-连环蛋白活性的结直肠癌致癌基因
  • DOI:
    10.1038/nature07179
  • 发表时间:
    2008-09-14
  • 期刊:
  • 影响因子:
    48.500
  • 作者:
    Ron Firestein;Adam J. Bass;So Young Kim;Ian F. Dunn;Serena J. Silver;Isil Guney;Ellen Freed;Azra H. Ligon;Natalie Vena;Shuji Ogino;Milan G. Chheda;Pablo Tamayo;Stephen Finn;Yashaswi Shrestha;Jesse S. Boehm;Supriya Jain;Emeric Bojarski;Craig Mermel;Jordi Barretina;Jennifer A. Chan;Jose Baselga;Josep Tabernero;David E. Root;Charles S. Fuchs;Massimo Loda;Ramesh A. Shivdasani;Matthew Meyerson;William C. Hahn
  • 通讯作者:
    William C. Hahn

William C. Hahn的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('William C. Hahn', 18)}}的其他基金

Development of p300/CBP histone acetyltransferase inhibitors for oncogene-driven cancers
开发用于癌基因驱动癌症的 p300/CBP 组蛋白乙酰转移酶抑制剂
  • 批准号:
    10627744
  • 财政年份:
    2022
  • 资助金额:
    $ 34.48万
  • 项目类别:
Novel genetic dependencies in VRK2 methylated glioblastoma multiforme
VRK2甲基化多形性胶质母细胞瘤的新遗传依赖性
  • 批准号:
    10046375
  • 财政年份:
    2020
  • 资助金额:
    $ 34.48万
  • 项目类别:
Development and implementation of multiplex methods to understand the biology and heterogeneity of patient-derived cancer models
开发和实施多重方法来了解源自患者的癌症模型的生物学和异质性
  • 批准号:
    10004385
  • 财政年份:
    2020
  • 资助金额:
    $ 34.48万
  • 项目类别:
Systematic interrogation of the pancreatic cancer microenvironment in patient-derived specimens
系统研究患者来源标本中的胰腺癌微环境
  • 批准号:
    10250566
  • 财政年份:
    2017
  • 资助金额:
    $ 34.48万
  • 项目类别:
PROJECT 4: Interrogating PP2A Signaling in Human Cancers
项目 4:探究人类癌症中的 PP2A 信号传导
  • 批准号:
    9981674
  • 财政年份:
    2017
  • 资助金额:
    $ 34.48万
  • 项目类别:
Systematic interrogation of the pancreatic cancer microenvironment in patient-derived specimens
系统研究患者来源标本中的胰腺癌微环境
  • 批准号:
    10242454
  • 财政年份:
    2017
  • 资助金额:
    $ 34.48万
  • 项目类别:
Systematic identification of oncogenic KRAS synthetic lethal interactions
系统鉴定致癌 KRAS 合成致死相互作用
  • 批准号:
    9330127
  • 财政年份:
    2015
  • 资助金额:
    $ 34.48万
  • 项目类别:
Systematic identification of oncogenic KRAS synthetic lethal interactions
系统鉴定致癌 KRAS 合成致死相互作用
  • 批准号:
    9150537
  • 财政年份:
    2015
  • 资助金额:
    $ 34.48万
  • 项目类别:
The Dana-Farber Cancer Institute Cancer Target Discovery and Development Center
丹娜—法伯癌症研究所癌症靶标发现和开发中心
  • 批准号:
    9362809
  • 财政年份:
    2013
  • 资助金额:
    $ 34.48万
  • 项目类别:
The Dana-Farber Cancer Institute Cancer Target Discovery and Development Center
丹娜—法伯癌症研究所癌症靶标发现和开发中心
  • 批准号:
    9979771
  • 财政年份:
    2013
  • 资助金额:
    $ 34.48万
  • 项目类别:

相似海外基金

Impacts of hurricanes and social buffering on biological aging in a free-ranging animal model
飓风和社会缓冲对自由放养动物模型生物衰老的影响
  • 批准号:
    10781021
  • 财政年份:
    2023
  • 资助金额:
    $ 34.48万
  • 项目类别:
REU Site: Comparative Animal Model Approaches to Regeneration and Aging
REU 网站:再生和衰老的比较动物模型方法
  • 批准号:
    2243416
  • 财政年份:
    2023
  • 资助金额:
    $ 34.48万
  • 项目类别:
    Continuing Grant
Early life trauma and aging using a long-lived animal model
使用长寿动物模型研究早期生命创伤和衰老
  • 批准号:
    10369990
  • 财政年份:
    2022
  • 资助金额:
    $ 34.48万
  • 项目类别:
Early life trauma and aging using a long-lived animal model
使用长寿动物模型研究早期生命创伤和衰老
  • 批准号:
    10550195
  • 财政年份:
    2022
  • 资助金额:
    $ 34.48万
  • 项目类别:
Programming amylin secretion to slow brain aging - an animal model
编程胰淀素分泌以减缓大脑衰老——动物模型
  • 批准号:
    9412623
  • 财政年份:
    2017
  • 资助金额:
    $ 34.48万
  • 项目类别:
Developing the Zebrafish as an animal model for aging
开发斑马鱼作为衰老动物模型
  • 批准号:
    6684675
  • 财政年份:
    2003
  • 资助金额:
    $ 34.48万
  • 项目类别:
Neurogenesis in an Animal Model of Cognitive Aging
认知衰老动物模型中的神经发生
  • 批准号:
    6532568
  • 财政年份:
    2002
  • 资助金额:
    $ 34.48万
  • 项目类别:
Neurogenesis in an Animal Model of Cognitive Aging
认知衰老动物模型中的神经发生
  • 批准号:
    6339639
  • 财政年份:
    2001
  • 资助金额:
    $ 34.48万
  • 项目类别:
Animal model for studying inner ear mechanism of aging
研究内耳衰老机制的动物模型
  • 批准号:
    12671674
  • 财政年份:
    2000
  • 资助金额:
    $ 34.48万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
ANIMAL MODEL AND FUNCTIONAL CHANGES IN AGING
动物模型和衰老过程中的功能变化
  • 批准号:
    6396630
  • 财政年份:
    1999
  • 资助金额:
    $ 34.48万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了